Is immunotherapy here to stay in multiple myeloma?
Immune escape and impaired immune surveillance have been identified as emerging hallmarks of cancer.1 Multiple myeloma represents a genuine example of disrupted immune surveillance characterized by: impaired antibody production, deregulation of the T and natural killer cell compartment, disruption o...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2017-03-01
|
| Series: | Haematologica |
| Acceso en liña: | https://haematologica.org/article/view/7994 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|